Inhibrx Biosciences, Inc. (INBX) News
Track canonical SquawkNews coverage tagged to INBX, Inhibrx Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Inhibrx GAAP EPS -2.34 misses by 0.06; interest expense rises
Inhibrx reports GAAP EPS of -2.34, missing by 0.06, while interest expense jumps to $4.5M from $1.3M amid debt rising to $175M from $100M.
EARNINGS | Aug 13, 2026, 08:14 PM UTC
L
Inhibrx reports second-quarter 2026 financial results
Inhibrx (INBX) reports its second quarter 2026 financial results, with details provided in the company release.
EARNINGS | Aug 13, 2026, 08:05 PM UTC
L
Citizens healthcare analysts hold an analyst/industry conference call
Citizens healthcare analysts hold an analyst/industry conference call
EQUITY | Jul 13, 2026, 08:56 AM UTC